AGGRESSIVE 2-WEEK TRADING STRATEGY

December 8-19, 2025 | Quantum Llamas Portfolio

Generated: December 7, 2025 Trading Period: 11 days (Dec 8 - Dec 19, 2025) Strategy Code: QUANTUM-LLAMAS-DEC25

EXECUTIVE SUMMARY

Today is Sunday, December 7, 2025. This aggressive 2-week trading strategy targets 3-4x SPY returns (15-20% absolute gain) with a maximum acceptable loss of 10%. The portfolio consists of 4 dynamically discovered stocks across Technology, Consumer Cyclical, and Healthcare sectors, totaling €1,032.42 invested (81.2% utilization of €1,271.97 budget).

Key Takeaways:

• 4 stocks discovered via dynamic web search (NOT default tickers)
• Diversified sectors: 31% Tech, 50% Retail, 19% Healthcare
• Portfolio beta: 1.09 (higher volatility than market)
• Fee hurdle: 1.26% (acceptable but monitor closely)
• CRITICAL RISK: FOMC meeting Dec 17 falls within holding period
• All stocks AVOID earnings during Dec 8-19 window

RISK PROFILE

MARKET CONTEXT (December 7, 2025)

Market Assessment: Favorable conditions for aggressive positioning. VIX at 15.41 indicates low market fear, and SPY showing modest upward momentum. However, FOMC meeting Dec 17 poses significant macro risk.

RED FLAG SUMMARY & PRE-EXECUTION CHECK

Market-Wide Red Flags

CRITICAL - FOMC MEETING DECEMBER 17, 2025:

• Federal Reserve policy decision falls mid-window (day 10 of 11)
• HIGH IMPACT EVENT - Can trigger 2-5% market swings
• Portfolio beta 1.09 amplifies volatility

PM CLI Red Flag Analysis:

ECONOMIC RED FLAGS:
  • FOMC/Fed events on 2025-12-17

OVERALL RECOMMENDATION: MODERATE RISK STOCKS (4)
   Recommendation: Reduce position sizes, set tight stops

CRITICAL ISSUES:
  • FOMC meeting on 2025-12-17
   ⚠️  STRONG RECOMMENDATION: Consider timing trades around critical events

Stock-Specific Red Flags

Earnings Verification: ✅ ALL STOCKS CLEAR - No earnings dates Dec 8-19

Technical Red Flags

• MCHP: RSI 81.03 (extreme overbought), +23% weekly surge, MACD negative despite rally
• AEO: Gap down -4.5% (distribution signal?), +35% monthly = mean reversion risk
• ANF: Very high volatility 12.34%, +32.56% monthly surge, consolidation phase
• GMED: Bearish divergence (price near highs, RSI 37.5 oversold), low volume 0.5x avg

Decision Framework Assessment

Red Flag Count:

• FOMC (systematic risk): MAJOR - affects all 4 stocks equally
• Stock-specific flags: 4 total across portfolio (moderate)
• Technical overbought: 3 of 4 stocks extended after recent surges

Risk Decision: PROCEED WITH CAUTION

Mitigation Actions:

1. ✅ Reduce position sizes from aggressive to moderate (done - 81.2% utilization)
2. ✅ Set tight stop-losses (10% portfolio max, individual stops tighter)
3. ⚠️ CRITICAL: Consider early exit Dec 16 before FOMC if portfolio up >10%
4. ⚠️ Alternative: Accept FOMC volatility risk for full 2-week hold to Dec 19

User Acknowledgment Required: You must explicitly acknowledge FOMC risk before execution.

PORTFOLIO OVERVIEW

Position Summary

Total Portfolio Value: €1,032.42 (81.2% utilization) Cash Reserve: €239.55 (18.8%) Portfolio Beta: 1.09 (9% more volatile than SPY)

Sector Allocation

Technology (MCHP):              31.1% ████████████████
Consumer Cyclical (AEO + ANF):  37.7% ███████████████████
Healthcare (GMED):              12.3% ██████
Cash Reserve:                   18.8% █████████

Diversification Assessment: Good sector spread avoids concentration risk. Tech capped at 31%, retail split between two brands (AEO/ANF), healthcare provides defensive anchor.

INDIVIDUAL STOCK ANALYSIS

1. MCHP - Microchip Technology (35% Allocation)

Discovery Source: "Top weekly performer +22.86%, momentum breakout December 2025"

Graham Classification: SPECULATION (Fundamental Score: 2/5)

• ❌ Fails Graham defensive criteria (5 of 7 failed)
• ❌ Negative margin of safety (-289% overvalued)
• ❌ Trading at 3.9x Graham Number ($65.81 vs $16.94)
• Current TTM earnings: NEGATIVE (-$0.46 EPS)

Fundamental Analysis (Agent Report):

• P/E Ratio: 42.19 (forward) - FAIL Graham's 15x threshold
• P/B Ratio: 5.31 - FAIL Graham's 1.5x threshold
• Current Ratio: 2.31 - PASS (strong liquidity)
• Debt/Equity: 0.80 - PASS (manageable debt)
• Revenue Decline: -42.35% in 2025 (SEVERE contraction)

Technical Analysis (Agent Report):

• Trend: BULLISH but severely overbought
• RSI: 81.03 (EXTREME overbought - threshold 70)
• Technical Score: 3/5
• Warning: +23.17% weekly surge on low volume (1.1x avg) = potential false breakout
• Distance from Support: 26.9% air pocket below
• Key Levels: Support $60.86 (5-day MA), Resistance $73.65

Bull Case (Score: 3.5/5):

• Guidance raise Dec 2: High-end range, 12% YoY growth
• New energy-efficient power monitor launch (50% power reduction)
• Automotive semiconductor recovery accelerating
• Analyst upgrades: Needham $75, BofA $72, Rosenblatt $80
• Sector tailwinds: $697B global semiconductor sales 2025

Bear Case (Score: Running - not completed in time):

• Mean reversion risk after +23% weekly surge
• Negative GAAP earnings, 42% revenue decline
• Extreme valuation (84x PE on forward estimates)
• MACD negative despite price surge (divergence)
• 100.9% dividend payout ratio (unsustainable)

Position Rationale: Momentum trade on semiconductor recovery catalyst, NOT value investment. Recent surge validates guidance raise. High risk/high reward for 2-week window.

2. AEO - American Eagle Outfitters (30% Allocation)

Discovery Source: "Momentum stock +33.1% over 3 months, Zacks #1 Strong Buy"

Graham Classification: SPECULATION (Fundamental Score: 2.0/5)

• ❌ Fails Graham defensive criteria (6 of 7 failed)
• ❌ Negative margin of safety (-32.7%)
• Trading at $23.09 vs Graham Number $15.53
• Overvaluation: 7-97% above fair value range

Fundamental Analysis (Agent Report):

• P/E Ratio: 20.43 - FAIL (exceeds 15x)
• P/B Ratio: 2.50 - FAIL (exceeds 1.5x)
• P/E × P/B: 51.08 - FAIL (exceeds 22.5)
• Current Ratio: 1.63 - FAIL (below 2.0)
• Debt/Equity: 1.21 - FAIL (above 1.0)

Technical Analysis (Agent Report):

• Trend: BULLISH (strong uptrend)
• Technical Score: 3.5/5
• Gap Down -4.5%: Potential entry opportunity OR warning
• RSI: 39.46 (cooled from overbought - HEALTHY)
• Monthly Momentum: +35.03% (exceptional)
• Setup: "Overbought Pullback" pattern - consolidation before next leg
• Key Levels: Support $19.34 (SMA20/50), Resistance $24.66 (52-week high)

Bull Case (Score: 3.5/5):

• Record holiday sales: Q4 guidance raised to 8-9% comp growth
• Q3 earnings beat: Revenue $1.36B, +5.7% YoY, +4% comps
• Zacks Rank #1 Strong Buy (top 5% of stocks)
• Analyst capitulation: JPMorgan upgrade $14→$20, Telsey $18→$25
• NRF forecasts first-ever $1 trillion holiday season

Bear Case (Score: 4.5/5 - STRONG):

• EXTREME overbought: RSI 79.85, +35% monthly surge
• FOMC meeting Dec 9-10 (just 2 days away at time of analysis)
• Holiday retail apocalypse: Consumer spending expected -5% YoY
• Tariff margin compression: $20M Q3 impact (40bp gross margin hit)
• Valuation disconnect: P/E 20.43 vs retail sector 12-15x (40-70% premium)
• Downside risk: $17.50-19.50 (-15% to -24%)

Position Rationale: Holiday retail momentum with Zacks validation. Gap down -4.5% provides better entry than peak. High beta (1.42) amplifies sector trends. Bear case is strong but near-term catalysts support bounce.

3. ANF - Abercrombie & Fitch (20% Allocation)

Discovery Source: "Strong retail performer +5.24% Dec 1, momentum continuation"

Graham Classification: SPECULATION (Fundamental Score: 3.0/5)

• ❌ Fails Graham defensive criteria (5 of 7 failed)
• Current Ratio: 1.38 - FAIL (below 2.0)
• No dividend since 2020 - FAIL
• BUT: Attractive P/E 9.13 (PASS), exceptional ROE 40.89%

Fundamental Analysis (Agent Report):

• P/E Ratio: 9.13 - PASS (below 15x - cheapest in portfolio!)
• P/B Ratio: 3.56 - FAIL (exceeds 1.5x)
• Graham Number: $76.38 (current $94.87 = +24.2% premium)
• Intrinsic Value: $254.56 (62.7% margin of safety!)
• The Paradox: Exceptional business (40.89% ROE, 11 consecutive growth quarters) but fails defensive criteria

Technical Analysis (Agent Report):

• Trend: BULLISH with consolidation
• Technical Score: 3/5
• Pattern: Bullish Pennant/Triangle - continuation formation (70% breakout probability)
• Volatility: 12.34% (VERY HIGH) - 167.05% historic volatility
• Monthly Momentum: +32.56%
• RSI: 65.98 (cooled from overbought - healthy)
• Key Levels: Support $80.65 (SMA20/50), Resistance $103.00 (52-week high)
• Consolidation: Bullish continuation, not distribution (volume profile confirms)

Bull Case (Score: 4.0/5 - STRONG):

• Absurd valuation disconnect: 9.1x P/E despite 30% growth rates
• Analyst targets: Avg $189.71 (100% upside), UBS $220, JPMorgan $109
• 12 consecutive quarters of growth (not a fluke)
• Operating margin expansion: 0% (FY2023) → 14.6% (FY2025)
• Zero debt, $449M borrowing capacity (fortress balance sheet)
• Holiday retail tailwinds: NRF expects $1T+ holiday sales
• Hollister brand +16% growth carrying momentum

Bear Case (Score: 4.0/5 - STRONG):

• Valuation trap: +32.56% monthly surge despite margin compression
• Operating margin fell from 12.7% to 9.3% YoY (-340 bps)
• Flagship Abercrombie brand: -10% comp sales (only Hollister masking weakness)
• $90M tariff burden = 9% of net income (structural pressure)
• RSI 78.4 extreme overbought demands mean reversion
• CFO sold 100% of shares ($1.67M) at $90 on Dec 1 (insider selling at peak!)
• Downside risk: $65-$75 (-25% to -30%)

Position Rationale: Genuine retail turnaround at 9.1x P/E (cheapest in portfolio). Consolidation pattern near breakout. Very high volatility (12.34%) requires tight stops but provides explosive upside potential. Bear case is equally strong as bull case - use small position size (12.8%).

4. GMED - Globus Medical (15% Allocation)

Discovery Source: "Momentum stock with Zacks #1 rating, healthcare sector rotation"

Graham Classification: SPECULATION (Fundamental Score: 3.5/5)

• ❌ Fails Graham defensive criteria (4 of 7 failed)
• P/E: 29.48x - FAIL (2x Graham's 15x threshold)
• No dividend ever - FAIL
• BUT: Fortress balance sheet (4.07 current ratio, 10.7% debt/equity)

Fundamental Analysis (Agent Report):

• P/E Ratio: 29.48 - FAIL (38x on 3-year average)
• P/B Ratio: 2.77 - FAIL
• P/E × P/B: 81.66 - FAIL (3.6x Graham's 22.5 limit)
• Graham Number: $47.83 (trading at +90.5% premium!)
• Intrinsic Value: $81.89 (current -11.2% margin of safety)
• Quality vs Valuation Dichotomy: A-grade business at F-grade price
• Best Balance Sheet: $695M cash, $437M debt (net cash positive), 52x interest coverage

Technical Analysis (Agent Report):

• Trend: BULLISH but weakening
• Technical Score: 2/5 ⚠️ LOWEST of 4 stocks
• MAJOR CONCERN: Bearish divergence (price near highs, RSI 37.5 oversold)
• Monthly Momentum: +8.59% (WEAKEST of 4 - steady vs explosive)
• Volume: 0.5x average (DISTRIBUTION pattern - smart money selling)
• Key Levels: Resistance $92.48 (immediate), Support $86.76 (SMA20/50)
• Risk/Reward: 1:0.4 (TERRIBLE - risk $15.57 to make $6.00)
• Position in Range: 96% of 52-week range (no room to run)

Bull Case (Score: 4.0/5 - STRONG):

• Healthcare sector rotation (largest inflows since Q1 2021)
• Defensive positioning: Beta 1.07, lower volatility than tech/retail
• Dominant IP moat: 8,927 patents, 25% global spine market share
• Integration execution ahead: NuVasive synergies $170M (55% captured Year 1)
• Analyst upgrades: Morgan Stanley $100, Truist $105, avg target $93-98 (+7-14%)
• Diversification benefit score: 8/10 (reduces portfolio volatility)

Bear Case (Score: 4.05/5 - STRONGER):

• Valuation trap: +47.63% surge in one month to $91.10
• Momentum exhausted: +5.91% in 2 weeks barely beats SPY's +4.05%
• Integration risks: NuVasive + Nevro ongoing, Q1 2025 supply chain disruptions
• CFO insider selling: Sold 100% of shares ($1.67M) at $90 on Dec 1
• Sector underperformance: Medical devices 4.9% vs S&P 10.6% (2020-2025)
• Technical setup 2/8 = extremely weak
• Downside risk: $61-71 (-22% to -32%)

Position Rationale: Healthcare diversifier with defensive beta 1.07. Provides ballast against tech/retail volatility. However, weakest technical setup (2/8) and bear case slightly edges bull case. Smallest allocation (12.3%) reflects uncertainty. Consider this the "quality anchor" that may underperform but protects downside.

PORTFOLIO RISK METRICS

Fee Analysis

Fee Optimization: With €1,271.97 budget and 4 positions, fee hurdle is 1.26%. This exceeds the ideal 1.0% threshold but remains acceptable for aggressive strategy. Reducing to 3 positions would lower hurdle to 0.95%, but current diversification benefits outweigh marginal fee savings.

Recommended max positions by budget:

• €1,272 budget → 2-3 positions ideal (fee hurdle 0.6-0.9%)
• Current 4 positions → 1.26% hurdle (acceptable for aggressive)

Portfolio Composition

Weighted Portfolio Beta: 1.09

• MCHP (31.1% × 1.46): 0.45
• AEO (24.9% × 1.42): 0.35
• ANF (12.8% × 1.17): 0.15
• GMED (12.3% × 1.07): 0.13
• Total: 1.09

Interpretation: Portfolio is 9% more volatile than SPY. A 1% SPY move translates to expected 1.09% portfolio move.

Correlation Matrix (Estimated):

• MCHP ↔ AEO/ANF: Low correlation (Tech vs Retail)
• AEO ↔ ANF: High correlation (both retail apparel, same catalysts)
• GMED ↔ All: Low correlation (Healthcare defensive)

Concentration Risk: 37.7% in retail apparel (AEO + ANF) creates sector concentration. Both stocks move on same holiday retail sentiment. Consider this as ~1.5 positions rather than 2.

Scenario Analysis

Bull Scenario (30% probability):

• Market rallies +2% through FOMC, positive holiday retail data
• MCHP hits $73 (+11%), AEO hits $27 (+17%), ANF hits $110 (+16%), GMED hits $98 (+8%)
• Portfolio Gain: +12.5% = €1,161.62 total = €129.20 profit

Base Scenario (50% probability):

• Market flat to +1%, mixed FOMC reaction, choppy holiday retail
• MCHP $70 (+6%), AEO $25 (+8%), ANF $100 (+5%), GMED $95 (+4%)
• Portfolio Gain: +6.2% = €1,096.42 total = €64.00 profit

Bear Scenario (20% probability):

• Hawkish FOMC or market correction -2-3%, holiday retail disappointment
• MCHP $61 (-7%), AEO $21 (-9%), ANF $88 (-7%), GMED $85 (-7%)
• Portfolio Loss: -7.2% = €957.82 total = €74.60 loss

Expected Value: (30% × €129) + (50% × €64) + (20% × -€75) = €55.70 profit (+5.4%)

Max Drawdown Protection:

• 10% portfolio stop = €929.18 minimum
• Individual stops triggered before -10% portfolio level
• Diversification reduces likelihood of all positions hitting stops simultaneously

ENTRY TIMING SCHEDULE

Buy Day: Monday, December 8, 2025

Market Open Timing (CET):

• NYSE Opens: 15:30 CET (9:30 AM ET)
• Avoid first 30 minutes (15:30-16:00 CET) - volatile price discovery
• Optimal Entry Window: 16:00-17:00 CET (10:00-11:00 AM ET)
• Alternative: 20:00-21:00 CET (2:00-3:00 PM ET) afternoon session

Order Execution Plan:

Pre-Market Preparation (Before 15:30 CET):

1. Review S&P 500 futures (ES) and Nasdaq futures (NQ) levels
2. Check VIX - if >20, consider delaying entry
3. Scan for overnight news on each ticker
4. Set limit orders at desired entry prices

Entry Strategy by Stock:

MCHP (7 shares @ $65.81 = €395.66):

• DO NOT CHASE at market open if gapping up
• Wait for pullback to $64-65 range
• Limit order: $64.50
• If opens below $63: Reassess (breakout may be failing)
• Stop-Loss: $61.00 immediately after entry (-5.4%)

AEO (16 shares @ $23.09 = €317.31):

• Monitor gap fill behavior from Friday's -4.5% gap
• If rallies to fill gap at $24.18 on volume: Bullish continuation
• If fails to fill and breaks $22: Trend weakening
• Limit order: $22.80-23.20 range
• Stop-Loss: $21.50 (-7.2%)

ANF (2 shares @ $94.87 = €162.96):

• Currently in consolidation triangle
• Wait for intraday stabilization
• Limit order: $93.50-95.50 range
• Stop-Loss: $89.00 (-6.2%, below recent low)

GMED (2 shares @ $91.10 = €156.49):

• Weakest technical setup - LAST priority
• Only enter if others fill successfully
• Limit order: $90.00-91.50 range
• Stop-Loss: $86.50 (-5.1%, below SMA20/50)

Order Type: Limit Orders (NOT Market Orders)

• Market orders risk slippage on low-liquidity stocks
• Set limits 1-2% below current ask to avoid overpaying
• If not filled by 21:00 CET, reassess for Tuesday entry

Transaction Fees: €8.00 (4 positions × €2) charged by DEGIRO on execution

EXIT TIMING SCHEDULE

Sell Day: Friday, December 19, 2025 (Base Plan)

Alternative Exit: Monday, December 16 (Before FOMC)

⚠️ CRITICAL DECISION POINT:

Option A: Early Exit December 16 (RECOMMENDED IF UP >10%)

• Rationale: FOMC meeting Dec 17 introduces 2-5% volatility risk
• Trigger: If portfolio up >10% by Dec 16, take profits and exit
• Lock in gains rather than risk FOMC reversal
• Timing: Exit before 15:30 CET Dec 16 (before FOMC volatility)

Option B: Full Hold Through December 19 (Higher Risk/Reward)

• Rationale: Capture full 2-week momentum, accept FOMC volatility
• Requires: Confidence in portfolio resilience and risk tolerance
• Timing: Exit Dec 19 between 16:00-20:00 CET (avoid end-of-day rush)

Exit Strategy by Stock:

Profit-Taking Levels (Sell in Stages):

MCHP:

• Target 1: $70.30 (+6.8%) - Sell 50% of position (3-4 shares)
• Target 2: $73.65 (+11.9%) - Sell remaining shares
• Trailing Stop: If exceeds $75, move stop to $72 (protect gains)

AEO:

• Target 1: $25.89 (+12.1%) - Sell 50% of position (8 shares)
• Target 2: $27.13 (+17.5%) - Sell remaining shares
• Resistance: $24.66 (52-week high) - expect profit-taking, consider partial exit

ANF:

• Target 1: $109.10 (+15.0%) - Sell 50% of position (1 share)
• Target 2: $114.29 (+20.5%) - Sell remaining share
• Breakout Level: If breaks $100 on volume, trail stop at $95

GMED:

• Target 1: $97.10 (+6.6%) - Sell 50% of position (1 share)
• Target 2: $101.73 (+11.7%) - Sell remaining share
• Conservative: Given weak technical setup 2/8, consider exiting at $95 (+4.3%)

Stop-Loss Discipline:

• DO NOT REMOVE STOPS once set
• Stops protect against catastrophic loss (FOMC, market crash, company-specific disaster)
• If stopped out, accept loss and move to next opportunity
• Portfolio-Level Stop: If total value drops to €929 (-10%), exit all positions immediately

Transaction Fees: €8.00 (4 sells × €2) charged on exit

DECISION TREE - IF/THEN SCENARIOS

┌─────────────────────────────────────────────────────────┐
│        MONDAY DECEMBER 8 - ENTRY DECISION               │
└─────────────────────────────────────────────────────────┘
                          │
        ┌─────────────────┴─────────────────┐
        │                                   │
   S&P Futures                         S&P Futures
   UP >1%                              DOWN >1%
        │                                   │
        ▼                                   ▼
  Check VIX                           Check VIX
  VIX <18?                            VIX >25?
        │                                   │
    ┌───┴───┐                          ┌────┴────┐
   YES     NO                         YES       NO
    │       │                          │         │
    ▼       ▼                          ▼         ▼
 PROCEED  WAIT                      DELAY    REASSESS
 Full     1 Day                     Entry    Sentiment
 Entry
        │                                   │
        └─────────────────┬─────────────────┘
                          │
        ┌─────────────────┴─────────────────┐
        │   DECEMBER 9-15 - MONITORING      │
        └─────────────────┬─────────────────┘
                          │
            ┌─────────────┴─────────────┐
            │                           │
      Portfolio UP >10%           Portfolio UP 5-10%
            │                           │
            ▼                           ▼
    Consider Early Exit           Hold Through FOMC
    (Dec 16 before FOMC)         Monitor Closely
            │                           │
            └─────────────┬─────────────┘
                          │
        ┌─────────────────┴─────────────────┐
        │   DECEMBER 16-17 - FOMC DECISION  │
        └─────────────────┬─────────────────┘
                          │
            ┌─────────────┴─────────────┐
            │                           │
      Portfolio UP >10%           Portfolio UP <10%
            │                           │
            ▼                           ▼
    ✅ EXIT DEC 16                 Hold Through FOMC
    Lock In Gains                  Accept Volatility
                                        │
                                        ▼
                              FOMC Outcome Dec 17
                                        │
                    ┌───────────────────┼───────────────────┐
                    │                   │                   │
               Hawkish Fed         Dovish Fed          Neutral
            (Rates stay high)    (Rate cut hint)    (No surprise)
                    │                   │                   │
                    ▼                   ▼                   ▼
            Market Sells Off      Market Rallies      Choppy Action
                -2 to -3%           +1 to +2%          -0.5 to +0.5%
                    │                   │                   │
                    ▼                   ▼                   ▼
            ⚠️ EVALUATE STOPS    🎯 HOLD TO DEC 19    📊 REASSESS
            Exit if -5% or more   Capture Full Gains   Exit at targets

Specific Risk Triggers

STOP-LOSS TRIGGERS (Exit Immediately):

• Individual stock hits stop-loss price
• Portfolio value drops to €929.18 (-10%)
• VIX spikes above 30 (panic selling)
• Market circuit breaker triggered (rare but possible)

PROFIT-TAKING TRIGGERS (Partial Exit):

• Any stock hits Target 1 → Sell 50% of that position
• Portfolio up >15% → Take 50% off entire portfolio
• FOMC day (Dec 17) if portfolio up >10% → Exit 50-100%

RED FLAG TRIGGERS (Reassess Immediately):

• Negative news on any stock (earnings warning, lawsuit, management change)
• Retail sales data significantly worse than expected
• China economic data collapse (could trigger global risk-off)
• Fed Governor hawkish speech before FOMC

TIME STOP (No Matter What):

• December 19, 20:00 CET: Exit all remaining positions
• Do NOT hold overnight into weekend Dec 20-21
• Weekend gap risk unacceptable for 2-week strategy

RISK MANAGEMENT RULES

Position-Specific Stop-Losses:

• MCHP: $61.00 (-7.3%)
• AEO: $21.50 (-7.2%)
• ANF: $89.00 (-6.2%)
• GMED: $86.50 (-5.1%)

Break-Even Prices (Including Fees):

• MCHP: $66.48 (+1.01%)
• AEO: $23.38 (+1.26%)
• ANF: $97.20 (+2.45%)
• GMED: $93.43 (+2.56%)

Trailing Stop Strategy:

• Once any stock reaches +10%, move stop to break-even (+1-2.5%)
• Once any stock reaches +15%, move stop to +5%
• Once any stock reaches +20%, move stop to +10%
• Protects unrealized gains while allowing upside continuation

KEY EVENTS CALENDAR

December 8-19, 2025 Critical Dates

FOMC Meeting December 17, 2025:

• Time: 14:00 ET (20:00 CET)
• Expected: Rate decision + Jerome Powell press conference
• Market Impact: 2-5% intraday swing possible
• Portfolio Risk: Beta 1.09 amplifies to 2.2-5.5% potential move
• Management: Consider Dec 16 early exit if profitable

Economic Data Watch:

• Retail Sales (if released): High impact on AEO/ANF
• CPI/Inflation Data: Affects FOMC expectations
• Jobless Claims: Market sentiment indicator

MID-PERIOD CHECKPOINTS (Reduce Stress & Distraction)

User Preference: "Provide check-in time to reduce stress and distraction"

Checkpoint Schedule

📍 Checkpoint #1: Wednesday, December 10, 17:00 CET After FOMC Meeting Starts

Check:

• [ ] All positions entered successfully?
• [ ] Any stop-losses triggered?
• [ ] Portfolio P&L: __________
• [ ] Any breaking news on individual stocks?
• [ ] VIX level: __________ (concern if >20)

Decision:

• If portfolio down >5%: Tighten stops, consider reducing losers
• If portfolio up >5%: Consider taking partial profits on winners
• If portfolio -2% to +2%: Hold, continue monitoring

📍 Checkpoint #2: Monday, December 15, 10:00 CET Pre-FOMC Assessment (2 days before decision)

Check:

• [ ] Portfolio P&L: __________
• [ ] Any positions hit Target 1?
• [ ] Fed commentary or leaks over weekend?
• [ ] Market sentiment (futures, VIX): __________

Decision:

• If portfolio up >10%: STRONGLY CONSIDER exiting before FOMC (Dec 16)
• If portfolio up 5-10%: Prepare to exit 50% on Dec 16
• If portfolio flat to -5%: Hold through FOMC, accept volatility risk
• If portfolio down >5%: Reassess thesis - may need to cut losses

📍 Checkpoint #3: Tuesday, December 16, 14:00 CET FOMC DAY-BEFORE - FINAL DECISION POINT

Check:

• [ ] Portfolio P&L: __________
• [ ] Profit-taking decision: HOLD or EXIT?
• [ ] Fed fund futures pricing in surprise?
• [ ] Any risk events overnight (China data, geopolitics)?

Decision:

• If portfolio up >10%: ✅ EXIT NOW - Lock in gains, avoid FOMC risk
• If portfolio up 5-10%: Exit 50%, hold 50% through FOMC
• If portfolio up 0-5%: Your choice - calculated risk to hold or exit
• If portfolio down: Hold through FOMC - need volatility to recover

This is your LAST CHANCE to de-risk before FOMC.

📍 Checkpoint #4: Friday, December 19, 15:00 CET FINAL DAY - PRE-EXIT REVIEW

Check:

• [ ] Portfolio P&L: __________
• [ ] All profit targets checked?
• [ ] Any trailing stops need adjustment?
• [ ] Weekend headlines to avoid?

Decision:

• Begin systematic exit 16:00-20:00 CET
• Sell positions in order: Losers first, winners last
• Ensure all positions closed by 20:00 CET latest
• DO NOT HOLD OVER WEEKEND - Weekend gap risk unacceptable

Between Checkpoints:

• Set price alerts on your broker for stop-losses and targets
• Check portfolio once per day maximum (avoid overtrading)
• Ignore daily noise - focus on end-of-day closes
• Trust your plan - emotional decisions destroy returns

QUICK REFERENCE CARD

┌─────────────────────────────────────────────────────────┐
│  QUANTUM LLAMAS PORTFOLIO - QUICK REFERENCE            │
├─────────────────────────────────────────────────────────┤
│  Budget: €1,271.97 | Invested: €1,032.42 (81.2%)      │
│  Positions: 4 | Fees: €16.00 (1.26%) | Beta: 1.09     │
├─────────────────────────────────────────────────────────┤
│  Target Return: +15-20% | Max Loss: -10%               │
│  Buy: Dec 8 | Sell: Dec 19 (or Dec 16 if up >10%)     │
├─────────────────────────────────────────────────────────┤
│  POSITIONS:                                            │
│  • MCHP: 7 @ $65.81 | Stop $61.00 | Target $73.65    │
│  • AEO:  16 @ $23.09 | Stop $21.50 | Target $27.13    │
│  • ANF:  2 @ $94.87 | Stop $89.00 | Target $114.29   │
│  • GMED: 2 @ $91.10 | Stop $86.50 | Target $101.73   │
├─────────────────────────────────────────────────────────┤
│  ⚠️  CRITICAL: FOMC Dec 17 - Exit Dec 16 if up >10%   │
│  ⚠️  Portfolio stop-loss: €929.18 (-10%)              │
│  ⚠️  Time stop: Dec 19, 20:00 CET - EXIT ALL          │
└─────────────────────────────────────────────────────────┘

Emergency Contacts:

• DEGIRO Support: [Customer service number]
• Portfolio Value Tracker: [Your method]

Key Broker Settings:

• Ensure stop-loss orders are GTC (Good-Till-Canceled) or DAY orders renewed daily
• Confirm fractional shares disabled (whole shares only)
• Verify EUR account has sufficient funds for purchases

MULTI-AGENT ANALYSIS SUMMARY

Agents Deployed (16 Total)

Per-Stock Analysis (4 agents × 4 stocks = 16):

Key Findings by Agent Type:

Fundamental Analysts:

• Verdict: All 4 stocks classified as SPECULATION, not investment-grade
• None pass Graham's defensive investor criteria (need 5/7, all scored 2-3/7)
• MCHP: Most egregious (-289% margin of safety, trading at 3.9x Graham Number)
• ANF: Best fundamental quality (40.89% ROE, zero debt) but still overvalued
• Common issue: Excessive valuations after recent momentum surges

Technical Analysts:

• Best Setup: AEO (Score 3.5/5) - gap down creating entry opportunity
• Worst Setup: GMED (Score 2/5) - bearish divergence, distribution pattern
• Overbought Warning: MCHP RSI 81.03, AEO RSI 79.85 (extreme levels)
• Consolidation Patterns: ANF bullish pennant (70% continuation probability)
• Volume Concerns: GMED 0.5x avg volume (distribution), MCHP 1.1x (weak)

Bullish Researchers:

• Highest Conviction: ANF (Bull Score 4.0/5) - 9.1x P/E turnaround story
• Strongest Catalysts: MCHP guidance raise Dec 2, AEO holiday retail strength
• Sector Tailwinds: Semiconductors $697B 2025, retail $1T holiday season
• Analyst Support: Multiple upgrades across all 4 stocks in recent weeks

Bearish Researchers:

• Highest Bear Conviction: AEO (Bear Score 4.5/5), ANF & GMED (4.0/5 each)
• Common Risks: Extreme overbought conditions after massive monthly surges
• FOMC Risk: All 4 stocks flagged for Dec 17 volatility exposure
• Tariff Concerns: AEO $20M Q3 impact, ANF $90M burden, margin compression
• Insider Selling: ANF & GMED CFOs sold 100% of shares at peak prices

Risk-Reward Balance:

• Bull case and bear case are EVENLY MATCHED across portfolio
• This is appropriate for aggressive speculation (not one-sided bet)
• Success depends on timing (FOMC outcome) and execution (stops, targets)
• Expected value +5.4% reflects balanced risk/reward

AGENT COLLABORATION INSIGHTS

Stock Discovery Process:

• ✅ ZERO default tickers used (NVDA, AMD, TSLA, AAPL avoided)
• 34 unique tickers discovered via 10 targeted web searches
• 17 tickers researched using PM CLI
• 14 passed aggressive screening filters
• 7 shortlisted for final consideration
• 4 recommended for portfolio

Qwant Agent Quantitative Allocation:

• All 4 stocks scored 3.2/5 on quantitative factors
• Allocation weights based on:
  • Momentum scores (weekly/monthly performance)
  • Volatility ratios (risk-adjusted returns)
  • Beta levels (market correlation)
  • Volume trends (liquidity/accumulation)
• Portfolio construction favored diversification over concentration

Cross-Agent Consensus:

• Agreement: All stocks are speculation requiring strict risk management
• Disagreement: ANF fundamentals (business quality high, Graham score low)
• Synthesis: Use technical timing on fundamentally-challenged momentum plays
• Risk Management: Unanimous FOMC warning across all bear case agents

FINAL RECOMMENDATIONS & USER DECISION

Portfolio Approval Checklist

Before executing this strategy, confirm:

• [ ] I understand this is SPECULATION, not investment - All 4 stocks fail Graham criteria
• [ ] I can afford to lose 10% - Max loss €127.20 is acceptable to my financial situation
• [ ] I acknowledge FOMC risk Dec 17 - Willing to accept 2-5% volatility or exit Dec 16
• [ ] I will follow stop-losses religiously - No emotional attachment, cut losses when triggered
• [ ] I will use limit orders, not market orders - Avoid slippage and overpaying
• [ ] I will check portfolio at designated checkpoints - Dec 10, 15, 16, 19 only
• [ ] I will exit by Dec 19, 20:00 CET no matter what - No weekend exposure
• [ ] I have €16 in fees budgeted - Total cost to enter and exit positions

Modifications Available

If you want to adjust the strategy:

Reduce Risk:

• Cut to 3 positions (remove GMED, lowest technical score) → Fee hurdle 0.95%
• Cut to 2 positions (MCHP + AEO) → Fee hurdle 0.63%, less diversification
• Reduce allocation 50% → €516 invested, save €516 cash for next opportunity
• Exit Dec 16 guaranteed (before FOMC) → Lower upside but eliminate event risk

Increase Conviction:

• Reallocate: Remove GMED (weak technical), add to ANF (best value at 9.1x P/E)
• 40% MCHP, 30% AEO, 30% ANF allocation
• Higher concentration = higher risk but cleaner thesis

Alternative Approaches:

• Wait until after FOMC Dec 17 → Miss 2-week window but eliminate macro risk
• Scale in: Buy 50% positions Dec 8, add 50% after FOMC if down
• Sector focus: All retail (AEO + ANF only) or all tech (MCHP only + add semiconductor)

Request different analysis:

• Run trading-desk agent for fuller multi-agent coordination
• Launch risk-manager agent for detailed position sizing optimization
• Request sentiment-analyst for contrarian Mr. Market assessment

SOURCES & DATA PROVENANCE

Market Data:

• PM CLI (uv run pm market) - December 7, 2025, 15:47:33 CET
• EUR/USD: 1.1643 from real-time PM CLI query

Stock Discovery:

• 10 targeted web searches (December 2025 market opportunities)
• Morningstar, Zacks, Nasdaq, NerdWallet, Seeking Alpha, Daily Forex, CSIMarket

Individual Stock Research:

• PM CLI (uv run pm research <TICKER>) - Comprehensive data for all 4 stocks
• PM CLI (uv run pm technical -t <TICKER>) - Technical analysis data
• PM CLI (uv run pm check -t <TICKER>) - Red flag verification

Multi-Agent Analysis:

• Fundamental-analyst agents (4): Graham-style defensive criteria assessment
• Technical-analyst agents (4): Chart patterns, RSI, MACD, support/resistance
• Bullish-researcher agents (4): Bull case thesis with catalysts and targets
• Bearish-researcher agents (3, 1 timeout): Bear risks and downside scenarios
• Stock-data-analyst agent (1): Dynamic discovery and screening coordination
• Qwant agent (1): Quantitative factor scoring and allocation weighting

Referenced Documentation:

• resources/intelligent-investor.md (Graham investment principles)
• .claude/commands/weekly-analysis.md (Strategy workflow guidelines)

Files Generated:

• Position sizing: output/position_sizing_dec7.json
• Red flag analysis: output/red_flag_analysis.json
• Market snapshot: output/market_snapshot_20251207_154733.json
• Individual stock research: output/{TICKER}_*.md (20+ files)

ACKNOWLEDGMENT OF RISKS

This strategy document represents SPECULATION, not INVESTMENT per Benjamin Graham's definition:

"An investment operation is one which, upon thorough analysis, promises safety of principal and an adequate return. Operations not meeting these requirements are speculative."

Risk Acknowledgments:

1. No Safety of Principal: All 4 stocks trade above intrinsic value with negative margins of safety
2. Timing Risk: 2-week window prevents long-term value realization
3. Event Risk: FOMC Dec 17 introduces macro uncertainty
4. Concentration Risk: 37.7% in retail apparel sector
5. Momentum Risk: Buying after 23-35% monthly surges risks mean reversion
6. Execution Risk: Stop-losses may gap below trigger prices in volatile markets
7. Fee Drag: 1.26% hurdle requires +1.55% return just to break even

This strategy is appropriate for:

• Traders comfortable with speculation and volatility
• Portfolios where 10% loss is acceptable and not catastrophic
• Aggressive risk profiles seeking 3-4x SPY returns
• Investors who can monitor positions at designated checkpoints

This strategy is NOT appropriate for:

• Graham-style defensive investors seeking safety of principal
• Conservative investors requiring low volatility
• Anyone unable to accept €127 max loss
• Investors who cannot monitor positions or execute stop-losses

By executing this strategy, you accept these risks and understand this is speculation.

FINAL SIGN-OFF

Strategy Approved By: [User Name] Date: December __, 2025 Signature: ___________________________

I acknowledge:

• This is a speculative 2-week trading strategy, not a long-term investment
• Maximum loss of 10% (€127.20) is acceptable
• I will follow stop-losses, profit targets, and exit schedule religiously
• FOMC meeting Dec 17 poses significant volatility risk
• I will exit all positions by Dec 19, 20:00 CET regardless of profit/loss

Good luck, and may Mr. Market be on your side for the next 11 days.

- Quantum Llamas Strategy Team Pasar Malam Portfolio Management December 7, 2025